IDNA · iShares Genomics Immunology and Healthcare ETF ETF
iShares Trust
$39.77
-1.29%
At close · Sep 4
Net assets $160,477,921
Holdings35
1 month
+14.35%
Year to date
+52.49%
52-week range
$22.33–$41.49
30-session avg volume
84,915
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000065599
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| REVOLUTION MEDICINES, INC. | RVMD | $10,999,959 | 6.85% |
| MODERNA, INC. | MRNA | $10,081,120 | 6.28% |
| MERCK & CO., INC. | MRK | $6,655,176 | 4.15% |
| BioNTech SE | BNTX | $6,533,178 | 4.07% |
| EXELIXIS, INC. | EXEL | $6,092,220 | 3.80% |
| Twist Bioscience Corp | TWST | $6,075,059 | 3.79% |
| REGENERON PHARMACEUTICALS, INC. | REGN | $5,983,142 | 3.73% |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | $5,703,386 | 3.55% |
| INCYTE CORPORATION | INCY | $5,648,654 | 3.52% |
| IDEAYA Biosciences Inc | IDYA | $4,348,529 | 2.71% |
| Immunitybio Inc | IBRX | $4,188,574 | 2.61% |
| CARIS LIFE SCIENCES, INC. | CAI | $3,907,749 | 2.44% |
| ARCUS BIOSCIENCES, INC. | RCUS | $3,406,775 | 2.12% |
| CRISPR Therapeutics AG | CRSP | $2,896,286 | 1.80% |
| NOVAVAX, INC. | NVAX | $2,096,258 | 1.31% |
| Iovance Biotherapeutics Inc | IOVA | $1,995,450 | 1.24% |
| Nuvation Bio Inc | NUVB | $1,898,557 | 1.18% |
| Vir Biotechnology Inc | VIR | $1,711,748 | 1.07% |
| ABCELLERA BIOLOGICS INC. | ABCL | $1,706,849 | 1.06% |
| Corvus Pharmaceuticals Inc | CRVS | $1,551,932 | 0.97% |
| Janux Therapeutics Inc | JANX | $1,378,701 | 0.86% |
| Kura Oncology Inc | KURA | $1,328,650 | 0.83% |
| CytomX Therapeutics Inc | CTMX | $962,325 | 0.60% |
| Ocugen Inc | OCGN | $949,234 | 0.59% |
| RIGEL PHARMACEUTICALS, INC. | RIGL | $910,726 | 0.57% |
| INTELLIA THERAPEUTICS, INC. | NTLA | $897,674 | 0.56% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | $768,008 | 0.48% |
| Design Therapeutics Inc | DSGN | $758,350 | 0.47% |
| Ginkgo Bioworks Holdings Inc | DNA | $636,979 | 0.40% |
| VERASTEM, INC. | VSTM | $634,867 | 0.40% |
| Alvotech SA | ALVO | $629,186 | 0.39% |
| Personalis Inc | PSNL | $522,578 | 0.33% |
| Xencor Inc | XNCR | $484,883 | 0.30% |
| Prime Medicine Inc | PRME | $201,519 | 0.13% |
| Mereo BioPharma Group PLC | MREO | $62,440 | 0.04% |